Rothschild Investment LLC’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$959 Buy
70
+45
+180% +$617 ﹤0.01% 2496
2025
Q1
$277 Sell
25
-55
-69% -$609 ﹤0.01% 2780
2024
Q4
$852 Buy
80
+50
+167% +$533 ﹤0.01% 2305
2024
Q3
$381 Buy
+30
New +$381 ﹤0.01% 2550
2018
Q4
Sell
-4,250
Closed -$201K 387
2018
Q3
$201K Buy
+4,250
New +$201K 0.02% 356